Cem Zorlular | Source | CEO at Er-Kim Pharmaceuticals
Cem Zorlular
Cem is Chief Executive Officer of Er-Kim Pharmaceutical. The company broadens and accelerates global patient access to innovative treatments by offering pharma and biotech companies of all sizes flexible, sustainable, and compelling business models to commercialize their products in international markets.
-
Behind closed doors: Family members tell us why they joined the family business
To understand more about what goes into this decision and the challenges and opportunities inherent in joining the family business, we talked to several next-gen family members – including a brother and sister who took different paths before making the leap, two brothers whose careers have mirrored each other, and an oldest child who followed her father across the Atlantic.
Article -
Facing The Drug Launch Challenge As A New CEO
Economic instability, geopolitical struggles, market access, pricing, and regulatory differences — among many other issues — can present themselves at any time before, during, or after the launch. What is important is how a CEO manages the steps toward launch success.
Article -
Cell and gene therapy manufacturing: trends, advancements and challenges
Read more about the current state of cell and gene therapy manufacturing, from remaining challenges to recent progress.
Article
-
AI Lag in Europe: Impact on Biotech Sector Efficiency
Cem highlights how Europe's AI lag affects biotech, leading to increased costs, longer timelines, and reduced efficiency. He notes, "Addressing these challenges is crucial for the sector's growth and competitiveness."
